Self-calibrated Magnetic Aptamer Sensor with Dual Lanthanide-assisted Time-resolved Luminescence for High-sensitive Detection of Melanoma Exosomal PD-L1
Self-calibrated Magnetic Aptamer Sensor with Dual Lanthanide-assisted Time-resolved Luminescence for High-sensitive Detection of Melanoma Exosomal PD-L1
复制标题
DOI：
10.1016/j.matdes.2023.111714
复制
发表时间：
2023-02
期刊：
影响因子：
--
通讯作者：
Nanhang Zhu;Xuekang Wang;Yujia Zhang;Yanchao Mao;Yue Yu;Qiangying Yi;Yao Wu
中科院分区：
文献类型：
--
作者：
Nanhang Zhu;Xuekang Wang;Yujia Zhang;Yanchao Mao;Yue Yu;Qiangying Yi;Yao Wu
Highly sensitive detection of melanoma-derived exosomal PD-L1 plays a key role in non-invasive diagnosis of melanoma. Here, we proposed a self-calibrated magnetic aptamer sensor (sCMAS) for sensitive detection of melanoma exosomal PD-L1, using the dual lanthanide-assisted luminescence as well as the ratiometric fluorescent probe strategy to overcome limitations caused by systematic or environmental factors, thereby providing a more stable and liable detection output. Generally, the sCMAS employs the Tb-based nanoparticles (TbNps), which were immobilized on magnetic Fe3O4microparticles, for stable luminescent reference signal report and the BHHCT-Eu3+complex for detection signal report of the specific exosomal PD-L1 recognition. Particularly, the dual time-resolved luminescent elements were bridged through the PD-L1-responsive aptamer and its complementary DNA hybridization chain. Recognition of exosomes with the aptamer expelled the detection signal (BHHCT-Eu3+) only, leading to an exosome concentration-dependent liner increase of reference signal/detection signal ratio value in a broad concentration range (1.05 × 105–1.05 × 1010particles/mL), and an extremely low calculated detection limitation of 1.88 × 102particles/mL. Further, sCMAS allowed a rapid and efficient differentiation of the health samples from melanoma samples, even those early metastatic melanoma cases. Promisingly, this sCMAS developed in this work would provide a vast opportunity for future evaluation of tumor markers (exosomes, cells, proteins, etc.), and will provide a powerful tool in liquid biopsies.
